Tumor type is a determinant of susceptibility to apoptosis - PubMed (original) (raw)
Comparative Study
Tumor type is a determinant of susceptibility to apoptosis
M J Staunton et al. Am J Clin Pathol. 1995 Mar.
Abstract
Little quantitative data exist on the extent of apoptosis (genetically-mediated cell deletion) in different human tumor types. Hematoxylin and eosin-stained paraffin sections of 102 malignant tumors (58 types) were evaluated for apoptotic cells and apoptotic bodies, using the 40x objective with a calibrated eye-piece and avoiding necrotic zones. The percentage of apoptotic cells and apoptotic bodies in the total number of tumor cells examined was designated as the apoptotic index (AI) for each case. There was a wide range in the AI for different tumor types: 45 tumors had AI < 1% and 93 had an AI of < 7%. In 107 additional tumors (11 types), the AI was determined to be within the same low, intermediate, or high range as the index cases. Apoptotic nuclear material was usually more prominent than mitoses. These results suggest that each tumor type has a characteristic AI that reflects innate tumor cell susceptibility to undergo apoptosis. Additional data are needed to determine whether significant variations in AI correlate with altered proliferative indices, aberrant oncogene/tumor suppressor gene expression, and standard clinicopathologic variables.
Similar articles
- Terminal uridine nick end labelling and mitosis in breast carcinoma. Correlation with tumor grade and p53 overexpression.
Dey P, Luthra UK, George SS, Haji BI, George J. Dey P, et al. Anal Quant Cytol Histol. 2001 Feb;23(1):27-30. Anal Quant Cytol Histol. 2001. PMID: 11233740 - Correlations between mitotic and apoptotic indices, number of interphase NORs, and histological grading in squamous cell lung cancer.
Cemerikić-Martinović V, Trpinac D, Ercegovac M. Cemerikić-Martinović V, et al. Microsc Res Tech. 1998 Mar 1;40(5):408-17. doi: 10.1002/(SICI)1097-0029(19980301)40:5<408::AID-JEMT7>3.0.CO;2-M. Microsc Res Tech. 1998. PMID: 9527050 - Non-mesenchymal Mimics of Sarcoma.
Doyle LA. Doyle LA. Surg Pathol Clin. 2015 Sep;8(3):493-513. doi: 10.1016/j.path.2015.05.010. Surg Pathol Clin. 2015. PMID: 26297067 Review. - Lung tumours: a personal review.
Steele RH. Steele RH. Diagn Histopathol. 1983 Jul-Dec;6(3-4):119-69. Diagn Histopathol. 1983. PMID: 6327213 Review. No abstract available.
Cited by
- Expression of cell cycle-regulatory proteins, MIB-1, p16, p53, and p63, in squamous cell carcinoma of conjunctiva: not associated with human papillomavirus infection.
Jung SM, Lin HC, Chu PH, Wu HH, Shiu TF, Huang SL, Lai CH. Jung SM, et al. Virchows Arch. 2006 Mar;448(3):301-5. doi: 10.1007/s00428-005-0104-2. Epub 2005 Dec 3. Virchows Arch. 2006. PMID: 16328355 - Apoptosis and proliferative activity in thyroid tumors.
Yoshida A, Nakamura Y, Imada T, Asaga T, Shimizu A, Harada M. Yoshida A, et al. Surg Today. 1999;29(3):204-8. doi: 10.1007/BF02483007. Surg Today. 1999. PMID: 10192728 - Maslinic Acid Inhibits Proliferation of Renal Cell Carcinoma Cell Lines and Suppresses Angiogenesis of Endothelial Cells.
Thakor P, Song W, Subramanian RB, Thakkar VR, Vesey DA, Gobe GC. Thakor P, et al. J Kidney Cancer VHL. 2017 Mar 21;4(1):16-24. doi: 10.15586/jkcvhl.2017.64. eCollection 2017. J Kidney Cancer VHL. 2017. PMID: 28405545 Free PMC article. - Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China.
Wang LD, Zhou Q, Wei JP, Yang WC, Zhao X, Wang LX, Zou JX, Gao SS, Li YX, Yang C. Wang LD, et al. World J Gastroenterol. 1998 Aug;4(4):287-293. doi: 10.3748/wjg.v4.i4.287. World J Gastroenterol. 1998. PMID: 11819301 Free PMC article. - Significance of apoptosis in metastasizing testis tumors.
Abend M, Port M, Schmelz HU, Kraft K, Sparwasser C. Abend M, et al. Urol Res. 2004 Feb;32(1):28-35. doi: 10.1007/s00240-003-0370-x. Epub 2003 Oct 25. Urol Res. 2004. PMID: 14579108
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources